Increase in the Authorized Share capital of the Company from Rs. 60,00,00,000 (Rupees Sixty Crores) to Rs. 200,00,00,000 (Rupees Two Hundred Crores) subject to approval of the Members of the Company.
Awaiting price reaction for this filing.
The board of Bijoy Hans Ltd, at a meeting on March 17, 2026, approved a major overhaul of the company. Key decisions include changing the company name to 'Arvaya Healthcare Limited' to reflect its business direction, and tripling the authorised share capital from Rs. 60 crore (6 crore shares of Rs. 10 each) to Rs. 200 crore (20 crore shares of Rs. 10 each). The board also raised the borrowing limit to Rs. 200 crore and approved investment/loan limits of Rs. 200 crore under Section 186. Mr. Salil Shetty will move from Non-Executive Director to Executive Director and CEO from April 1, 2026, and remuneration has been revised for the Managing Director and CFO. Additionally, a non-binding Letter of Intent was issued to GTT Data Solutions Ltd for a technology platform deal worth up to Rs. 5 crore, payable in cash or equity. All major resolutions will go to shareholders via a postal ballot.
For shareholders, the name change signals a strategic pivot toward healthcare, while the sharply higher authorised share capital gives the company room to raise fresh equity or issue bonus shares in the future. The increased borrowing and investment limits suggest plans for expansion or acquisitions. Shareholders should watch the postal ballot outcome, as these changes could dilute holdings or alter the company's risk profile.